Project Grant R21AI190686
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $439,896 Project Grant to William Marsh Rice University under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period July 16, 2025 through June 30, 2027. The grant supports research targeting multidrug-resistant (MDR) Pseudomonas aeruginosa through the development and characterization of R pyocins—phage tail-like protein complexes that demonstrate...
- Federal Project Grant Award Summary William Marsh Rice University received a $421,673 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 24, 2025, with a completion date of June 30, 2027. The award supports the development of foundational computational tools and laboratory methods to identify and detect signature regions of antimicrobial resistant pathogens for wastewater...
- Federal Project Grant Award Summary William Marsh Rice University received a $409,024 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 6, 2026, with completion targeted for January 31, 2028. The research initiative, titled "Characterization and Structure-Guided Targeting of Plasmodium falciparum Apicoplast DNA Polymerase," focuses on developing novel...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $440,000 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston for a two-year project period (August 1, 2025 – July 31, 2027). This Project Grant funds biomedical research investigating the pathogenic mechanisms of rickettsioses, devastating human infections that disproportionately affect microvascular...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $444,125 to The Methodist Hospital Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 8, 2025, for a two-year project concluding July 31, 2027. This Project Grant supports investigator-initiated biomedical research focused on characterizing a novel intercellular signaling pathway in Group B Streptococcus (GBS), a major human pathogen...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $576,501 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, with completion scheduled for July 31, 2030. This research project investigates the previously uncharacterized role of nucleoprotein (NP) exoribonuclease in Lassa virus (LASV) replication and fitness. The award...
- Federal Grant Award Summary Texas A&M Engineering Experiment Station received a $637,275 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 28, 2025, with completion targeted for April 30, 2030. This research initiative investigates rapid stress response mechanisms in gram-negative bacterial pathogens, specifically examining how existing porins in outer membranes contribute...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $709,891 Project Grant on August 1, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support a five-year research project extending through July 31, 2030. The award funds structural and mechanistic research on the polar tube invasion apparatus of microsporidian parasites, unicellular fungal pathogens that cause opportunistic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tulane University $382,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning August 1, 2025, with a completion date of July 31, 2030. This Project Grant funds basic immunological research investigating the regulatory mechanisms and biological functions of cyclic GMP-AMP synthase (cGAS) in the nucleus. The research deliverables encompass three primary...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $382,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Tulane University, effective June 20, 2025, with a completion date of May 31, 2030. This award funds fundamental biomedical research investigating the role of Taxilin Alpha (TXLNA) in cytosolic DNA-mediated innate immunity. The research addresses a significant gap in understanding how the...
Award Details:
The National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded a Project Grant of $422,698.00 to William Marsh Rice University on February 6, 2026, with completion targeted by January 31, 2028. The research will be conducted at Rice University's Houston, Texas campus. Research Deliverables and Services:
This project grant funds investigator-initiated biomedical research investigating how the innate immune system shapes the adaptation and emergence of opportunistic bacterial pathogens. The research employs a high-throughput experimental approach combining microfluidics technology, in vitro experimental evolution, and genomic/phenotypic characterization to examine interactions between environmental bacteria and an in vitro innate immune system model comprising both humoral and cellular immune components. The primary deliverables include: (1) identification of how humoral and cellular innate immune responses eliminate diverse environmental microbes, and (2) characterization of adaptive mechanisms and traits that microbes develop in response to innate immune challenges. These research outputs will advance scientific understanding of pathogen emergence mechanisms and inform strategies for mitigating infectious disease threats posed by emerging and pre-emergent pathogens that transition from environmental reservoirs to human hosts.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $422.7k | 2/6/26 |